TY - JOUR T1 - Assessment of medical undergraduates’ relation to pneumococcal conjugate vaccine use JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2021.PA535 VL - 58 IS - suppl 65 SP - PA535 AU - Roman Bontsevich AU - Kristina Shchurovskaya AU - Galina Batisheva AU - Natalya Goncharova AU - Ann Adonina AU - Anna Gavrilova AU - Tatyana Pokrovskaia Y1 - 2021/09/05 UR - http://erj.ersjournals.com/content/58/suppl_65/PA535.abstract N2 - The aim of work is to reveal the relation of medical undergraduates to pneumococcal conjugate vaccine (PCV) use.Methods: In terms of multicenter research ‘KnoCAP’ we developed an original questionnaire to assess the relation of medical undergraduates to PCV use. Possible answers were the following: “positive, recommended by indications”, “negative, I find it ineffective or dangerous”, “indefinite relation (due to some reasons)”, “never heard about such vaccination”, “other”.  An anonymous surveying was conducted among the medical undergraduates (5-6 grades) in universities of Belgorod and Voronezh, including 34 students in 2014-2015, and 65 in 2017.Results: The study showed the following results:· There were only 35.1% of students who had a positive relation to pneumovaccine in 2014-2015, while in 2017 the number of such respondents increased significantly (47.6%, p <0.05).· Almost same percentage of the respondent (8.1% and 9.2%) had negative or indefinite relation to PCV.· The level of awareness also increased significantly in dynamics: 37.8% of students did not know about this vaccine in 2014-2015, while in 2017 there were only 3.1% of those (p <0.01).Conclusions: During the study, it was revealed that students’ awareness and positive relation to PCV had significantly increased. However, despite the availability of clinical recommendations, the current level of knowledge in preventive vaccination cannot be considered as satisfactory. We believe that pneumonia preventive methods should be studied in more detail in medical universities.FootnotesCite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA535.This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only). ER -